Oncology Resource Group

Oncology Resource Group serves pharmaceutical and biotechnology developers worldwide by delivering best-in-class market planning and competitive intelligence reports through ONCrgs expert advisors in solid tumor, hematologic malignancy, emerging + late stage immuno-oncology, and MOA drug markets. ONCrg was founded by senior consultants, Stacey McCann and Michael D. Reynolds, with a vision to add value to client programs through focused expertise in oncology drug markets and broader and deeper market planning resources than our competitors; where their capabilities are attenuated by working in too many non-drug and non-oncology market sectors. Our fundamental belief is that clients are better served by putting all of our firms analytical efforts and capabilities behind the exclusive study of oncology markets so we can deliver market planning resources with more depth, insight, and precision than would otherwise be possible. We are committed to helping our clients succeed in creatin...